Abstract: A housing or pocket for supporting a light guide device for an illumination device, especially for a motor vehicle or an indicator device in a rearview device of a motor vehicle. The housing has a first side which is configured to support the light guiding device for exposure to the pictogram of the reflection layer. The housing also include a second side containing exposed wire connectors to connect the light guide device to a power source. One of the light guide device, the printed circuit board or both structures are fitted with an encapsulation member and secured to the housing through the use of a fixative mount.

Abstract: A peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides is described. An anti-inflammatory composition comprising the above mentioned peptides is described. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating a variety of different types of inflammatory diseases.

Abstract: The disclosure is related to managing a resource change in a machine to machine (M2M) network. Managing the resource change in M2M network by creating an abstract M2M entity object associated with a resource change, and creating an M2M entity object instance by embodying the abstract M2M entity object according to each application development environment.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO:1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO:1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides is described. An anti-inflammatory composition comprising the above mentioned peptides is described. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, the peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides is described. An anti-inflammatory composition comprising the above mentioned peptides is described. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating a variety of different types of inflammatory diseases.

Abstract: A peptide with anti-inflammatory activity is described, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising those peptides can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid sequence with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, the peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A touch information communication method transmits notification information to the touch screen information providing apparatus by carrying the notification information, which notifies a touch communication terminal is a touch communication terminal, on a call signal in a telephone communication network; receives touch screen information and touch control information corresponding to the touch screen information from the touch screen information providing apparatus; and when a user touches a predetermined area on a screen, determines the touched area and transmits touch input information corresponding to the touched area to the touch screen information providing apparatus.

Abstract: The present disclosure is related to device management in a machine to machine (M2M) network. Particularly, the present disclosure relates to performing an efficient device management based on correlations between M2M devices in the M2M network.

Abstract: The disclosure is related to managing a resource change in a machine to machine (M2M) network. The disclosure may create an abstract M2M entity object associated with a resource change, and create an M2M entity object instance by embodying the abstract M2M entity object according to each application development environment.

Abstract: The present invention relates to a space-division multiple power feeding and collecting apparatus, and more specifically to a space-division multiple power feeding and collecting apparatus which is composed of multiple power feeding type lines using phase division, time division or frequency division and the like along a traveling direction of a moving body and receives electric power therethrough so as to feed the electric power to and to collect electric power from various moving bodies of a vehicle, and underwater moving body or a robot and the like in a non-contact manner.

Abstract: An organic electro-luminescence device includes a drive unit having first to fourth transistors and a capacitor, and an organic light emitting diode (OLED) controlled by the drive unit, wherein the first transistor has its gate, drain and source connected to a first node, a second node and a power voltage supply line, respectively; the second transistor has its drain and source connected to the OLED and the second node, respectively; the third transistor has its gate, drain and source connected to a first select signal line, the second node and the first node, respectively; the fourth transistor has its gate, drain and source connected to the first select signal line, a data line, and the second node, respectively; and the capacitor is connected to the first node and a predetermined signal line.

Abstract: A touch information communication method transmits notification information to the touch screen information providing apparatus by carrying the notification information, which notifies a touch communication terminal is a touch communication terminal, on a call signal in a telephone communication network; receives touch screen information and touch control information corresponding to the touch screen information from the touch screen information providing apparatus; and when a user touches a predetermined area on a screen, determines the touched area and transmits touch input information corresponding to the touched area to the touch screen information providing apparatus.

Abstract: An organic electro-luminescence device includes a drive unit having first to fourth transistors and a capacitor, and an organic light emitting diode (OLED) controlled by the drive unit, wherein the first transistor has its gate, drain and source connected to a first node, a second node and a power voltage supply line, respectively; the second transistor has its drain and source connected to the OLED and the second node, respectively; the third transistor has its gate, drain and source connected to a first select signal line, the second node and the first node, respectively; the fourth transistor has its gate, drain and source connected to the first select signal line, a data line, and the second node, respectively; and the capacitor is connected to the first node and a predetermined signal line.

Abstract: A method of driving an organic electroluminescent display device, including measuring a gray level of an image, turning on a sampling transistor connected to gate electrode and drain electrode of a driving transistor during a sampling time, applying a data voltage to operate the driving transistor, and supplying a current to an light emitting diode through the driving transistor.